Summary:
Metroplex Clinical Research Center is conducting a research study to evaluate the percentage of subjects who do not experience a flare on CZP Q2W (full-dose) or 200mg Q4W(half-dose) as compared to placebo (cZP withdrawal) during Part B.
Qualified Participants Must:
• Be between 18 and 45 years of age
•
Have a diagnosis of AS at least 3 months symptom duration but no more than 5 years
•
Have inadequate response to at least 2 NSAIDS
Qualified Participants May Receive:
$75 per visit.
Free Garage Parking